Intravenous Equipment Sales

Intravenous Equipment Sales Market Outlook

The global intravenous equipment sales market was valued at approximately $18 billion in 2023 and is projected to reach around $30 billion by 2033, expanding at a compound annual growth rate (CAGR) of about 5% during the forecast period. The increasing incidence of chronic diseases, alongside the growing need for effective patient management in both hospital and homecare settings, has significantly fueled market growth. Additionally, technological advancements in intravenous (IV) equipment, such as smart infusion pumps and enhanced safety features, have also contributed to the rising demand. Moreover, the ongoing trend towards outpatient care and the increasing preference for minimally invasive procedures are further propelling the market forward. The focus on improving patient outcomes and operational efficiencies in healthcare settings is expected to drive the ongoing adoption of intravenous equipment across various medical institutions.

Growth Factor of the Market

Several factors are driving the growth of the intravenous equipment sales market. Firstly, the rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders necessitates effective treatment options that often include intravenous therapy as a critical component. Additionally, the increasing aging population, which is more susceptible to health complications, further necessitates the use of IV equipment to ensure proper medical care. Secondly, advancements in medical technology, such as the development of smart IV pumps with integrated software that ensures safe medication delivery, play a significant role in enhancing patient safety and treatment efficacy. Moreover, the shift towards home healthcare is also contributing to the expansion of the market, as patients prefer receiving care in the comfort of their homes rather than in hospital settings. Furthermore, the rising awareness about patient safety and infection control is leading healthcare facilities to invest in high-quality intravenous equipment to minimize the risks associated with IV therapy.

Key Highlights of the Market

• The intravenous equipment market is projected to experience a robust growth rate of 5% CAGR from 2023 to 2033.
• The infusion pumps segment is anticipated to hold the largest market share due to their increasing utilization in hospitals and homecare settings.
• North America is expected to dominate the market, driven by advanced healthcare infrastructure and high healthcare spending.
• The growing trend towards outpatient and homecare services is expected to significantly drive the demand for intravenous equipment.
• Technological advancements, such as wireless connectivity and smart pumps, are poised to enhance the safety and reliability of intravenous therapies.

By Product Type

Infusion Pumps:

Infusion pumps are a pivotal segment of the intravenous equipment sales market, primarily due to their extensive use in delivering medications, nutrients, and fluids to patients. These devices help in administering precise dosages, thereby reducing the risks of medication errors and ensuring optimal patient care. The market for infusion pumps has been significantly propelled by the increasing prevalence of chronic diseases that require long-term medication administration via intravenous routes. Furthermore, advancements in technology have led to the design of smart infusion pumps capable of providing real-time monitoring, alarms for potential errors, and data integration with electronic health records, thereby enhancing the safety and efficiency of IV therapy.

Intravenous Catheters:

Intravenous catheters represent another crucial segment within the intravenous equipment sales market. These devices are essential for facilitating the safe and effective delivery of medications, blood products, and fluids directly into the bloodstream. The growing demand for minimally invasive procedures has led to an increased preference for peripheral and central venous catheters. The market is also witnessing innovations, such as catheter designs with enhanced biocompatibility and anti-thrombogenic properties, which help in minimizing complications such as infections and occlusions. As healthcare providers emphasize patient safety and comfort, the demand for high-quality intravenous catheters continues to rise, contributing significantly to market growth.

Intravenous Cannulas:

Intravenous cannulas are widely used in clinical settings for their ability to provide quick and reliable venous access. They play a critical role in administering fluids, medications, and transfusions, thus making them integral to patient care. The increasing number of surgical procedures and the requirement for intravenous access in emergency situations have fueled the demand for intravenous cannulas. Moreover, the introduction of safety-engineered cannulas designed to prevent needlestick injuries has also contributed to the growth of this segment. As healthcare facilities prioritize infection control and patient safety, the adoption of advanced intravenous cannulas is anticipated to rise, further driving market expansion.

Intravenous Administration Sets:

Intravenous administration sets are essential components of intravenous therapy, responsible for delivering fluids and medications from the IV bag to the patient. These sets are designed to ensure accurate flow rates and minimize the risk of contamination and air embolism during administration. The increasing focus on patient safety and quality of care has driven the demand for high-quality, sterile administration sets that meet stringent regulatory standards. Additionally, the growing trend towards home healthcare is leading to an increase in the usage of portable administration sets, further propelling the market for IV administration sets. As innovations continue to enhance the functionality and safety of these devices, the demand for intravenous administration sets is expected to rise substantially.

Intravenous Needles:

Intravenous needles are fundamental tools in the intravenous equipment sales market, as they facilitate the insertion of intravenous catheters and provide access to the bloodstream for medication administration. The market for intravenous needles has seen advancements in design, such as the introduction of safety needles equipped with mechanisms to prevent needlestick injuries. The increasing awareness about infection control and the importance of safe needle practices has significantly contributed to the demand for high-quality intravenous needles. Furthermore, the growth of outpatient services and the trend toward home healthcare have further increased the need for easy-to-use and safe intravenous needle systems, driving market growth in this segment.

By Application

Hospitals:

Hospitals are the largest segment for intravenous equipment due to the extensive utilization of IV therapy in various clinical settings. Intravenous equipment is integral for administering medications, fluids, and nutrition to patients undergoing surgeries, treatments, or recovering from illnesses. The rising number of hospital admissions and the increasing prevalence of chronic diseases have led to a significant demand for intravenous equipment in hospitals. Moreover, with advancements in medical technology, hospitals are increasingly adopting sophisticated IV systems that offer enhanced safety and efficiency in medication delivery, thereby improving patient outcomes. The ongoing focus on optimizing patient care and reducing medication errors further solidifies the hospital segment's prominence in the intravenous equipment sales market.

Clinics:

Clinics, particularly specialty and outpatient clinics, are witnessing a growing demand for intravenous equipment as the trend towards outpatient treatment increases. These facilities often administer IV therapy for hydration, medication, and blood transfusions, thus requiring reliable and efficient intravenous systems. The convenience and accessibility of clinics have made them a preferred choice for patients requiring less intensive care, leading to an upsurge in the demand for intravenous equipment. Furthermore, advancements in portable IV systems are enabling clinics to provide safe and effective care outside of traditional hospital settings, contributing to the growth of this segment.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are increasingly adopting intravenous equipment to facilitate outpatient surgeries and procedures that require IV sedation or anesthesia. The growing preference for minimally invasive surgeries and the shift towards outpatient care have made ASCs a key segment in the intravenous equipment sales market. These centers prioritize patient safety and comfort, necessitating the use of high-quality intravenous systems with advanced monitoring features. The rise of ASCs, combined with the increasing volume of surgical procedures being performed on an outpatient basis, is driving the demand for intravenous equipment in this segment significantly.

Homecare Settings:

The homecare segment is rapidly becoming a significant driver of growth for the intravenous equipment sales market. With the rising trend towards providing care in the comfort of patients' homes, there is an increasing need for safe and effective IV therapy systems that can be easily managed by patients or caregivers. The growing prevalence of chronic diseases requiring long-term medication administration, as well as the aging population seeking more comfortable care options, are key factors contributing to this trend. Advances in portable infusion devices and user-friendly intravenous systems are further enhancing the feasibility of home-based IV therapy, thereby expanding the market potential in this segment.

Others:

The 'Others' application segment encompasses various healthcare settings such as long-term care facilities, palliative care units, and rehabilitation centers that also utilize intravenous therapy. These facilities often require intravenous equipment to provide necessary care for patients with complex health needs, particularly those requiring hydration, medication administration, or nutrition. As the healthcare landscape evolves with a focus on comprehensive patient management across diverse settings, the demand for intravenous equipment in these facilities is expected to grow. This segment plays a crucial role in ensuring that patients receive timely and effective treatment, thereby contributing to the overall market growth.

By End User

Hospitals:

Hospitals remain the primary end user of intravenous equipment, accounting for the largest share of the market. The high volume of patients requiring intravenous therapy for various treatments, including surgeries, critical care, and chronic disease management, drives the substantial demand for IV equipment within hospital settings. The integration of advanced intravenous systems equipped with safety features and monitoring capabilities enhances the quality of care provided in hospitals, ensuring accurate medication delivery and reducing the risks of complications. As healthcare systems continue to expand and invest in advanced medical technologies, hospitals will likely maintain a significant demand for intravenous equipment to support their operational needs and improve patient outcomes.

Specialty Clinics:

Specialty clinics serve as another crucial end user of intravenous equipment, specifically those focused on areas such as oncology, cardiology, and pain management. These clinics frequently administer intravenous therapies tailored to treat specific medical conditions, which necessitates the use of specialized intravenous equipment. The rising number of specialty clinics due to the increasing prevalence of chronic diseases has created a robust market for intravenous products designed for targeted therapies. Additionally, the emphasis on patient-centered care and tailored treatment plans has further propelled the demand for advanced intravenous systems within specialty clinics, driving growth in this segment.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are increasingly recognized as key end users of intravenous equipment, particularly for outpatient procedures requiring anesthesia or IV sedation. The growing trend towards minimally invasive surgical techniques and patient preference for outpatient care are driving the demand for reliable intravenous systems that ensure patient safety and comfort. ASCs prioritize efficiency and effective patient management, and the availability of advanced intravenous devices that streamline medication delivery plays a significant role in their operations. As the number of ASCs continues to rise, so will the demand for intravenous equipment tailored to the outpatient surgical environment.

Homecare Settings:

Homecare settings are rapidly emerging as significant end users of intravenous equipment, driven by the increasing trend towards providing care in patients' homes. The need for intravenous therapy in homecare environments is often associated with chronic disease management, palliative care, and rehabilitation. As patients prefer receiving care in familiar surroundings, the demand for portable and user-friendly intravenous systems has surged. Additionally, advancements in technology have led to the development of sophisticated yet easy-to-use devices suitable for homecare, ensuring patient safety and promoting independence. This segment is poised for substantial growth as more healthcare providers embrace homecare models.

Others:

The 'Others' category includes various healthcare facilities such as long-term care facilities, rehabilitation centers, and palliative care units, which also utilize intravenous therapy. These settings often cater to patients requiring complex medical care and may have a diverse array of intravenous needs, from hydration to medication administration. The growing focus on holistic and personalized patient care is driving demand for intravenous equipment across these facilities. The integration of advanced intravenous systems that cater to the specific needs of diverse patient populations will likely support the growth of this segment, ultimately contributing to the overall expansion of the intravenous equipment market.

By Distribution Channel

Direct Sales:

Direct sales represent a significant distribution channel in the intravenous equipment market, allowing manufacturers to establish direct relationships with healthcare providers, hospitals, and clinics. This channel enables manufacturers to provide tailored solutions, ensuring that clients receive the specific products suited to their operational needs. Direct sales also facilitate better customer service and support, including training on the use of intravenous equipment, which is crucial for safety and efficacy. Moreover, manufacturers can gather firsthand feedback from end users, enabling them to enhance product offerings continually. As healthcare organizations aim for streamlined procurement processes, the direct sales model is likely to maintain a strong presence in the intravenous equipment market.

Distributor Sales:

Distributor sales serve as another essential channel for the intravenous equipment market, allowing manufacturers to reach a broader customer base through established distribution networks. Distributors often have extensive experience in the healthcare sector, enabling them to effectively manage logistics, inventory, and supply chain challenges. This channel plays a critical role in ensuring that intravenous equipment is accessible to various healthcare settings, especially those in remote or underserved areas. Furthermore, distributor partnerships can enhance market penetration, allowing manufacturers to focus on product development while leveraging distributors' networks for efficient sales and support. As demand for intravenous equipment continues to grow, distributor sales will remain a vital avenue for market expansion.

By Region

The regional analysis of the intravenous equipment sales market reveals significant variations in demand and growth rates across different geographical areas. North America is expected to dominate the market, accounting for approximately 40% of the global share in 2023, driven by advanced healthcare infrastructure, higher healthcare expenditures, and a growing aging population. The region's continuous innovations in medical technology, coupled with an increasing emphasis on patient safety and quality care, further bolster market growth. Furthermore, the rising prevalence of chronic diseases and the expansion of outpatient services are expected to contribute to a robust CAGR of around 6% in North America during the forecast period.

Europe stands as another key region in the intravenous equipment sales market, expected to hold a substantial share, accounting for around 30% of the global market. The growth in Europe is driven by the increasing adoption of advanced medical technologies, a robust healthcare system, and a rising emphasis on patient safety. Countries such as Germany, France, and the UK are at the forefront of this growth, with investments directed towards modernizing healthcare facilities and expanding outpatient care options. The Asia Pacific region is also anticipated to witness significant growth, primarily attributed to the increasing healthcare spending, expanding patient base, and rapid urbanization. As the region continues to enhance its healthcare infrastructure, the demand for intravenous equipment is expected to rise, although at a comparatively slower rate than North America and Europe due to existing market disparities.

Opportunities

The intravenous equipment sales market is poised to benefit from several burgeoning opportunities. One of the most significant opportunities lies in the expansion of home healthcare services. As patients increasingly prefer receiving care in their homes, there is a growing demand for portable and user-friendly intravenous devices that can be managed by caregivers or patients themselves. Manufacturers that innovate and invest in developing advanced homecare IV systems are well-positioned to capitalize on this trend. Additionally, the integration of telemedicine and remote monitoring technologies offers promising prospects for enhancing patient management and safety during home-based intravenous therapy, thus expanding market reach in this segment.

Another significant opportunity lies in the ongoing advancements in medical technology, particularly in IV systems equipped with integrated safety features and real-time monitoring capabilities. The development of smart infusion pumps and other IV devices that minimize risks associated with medication administration can create substantial market growth. Additionally, as regulatory bodies continue to emphasize patient safety and infection control, the demand for high-quality intravenous equipment that meets strict compliance standards is expected to rise. Healthcare providers are increasingly investing in advanced intravenous solutions to reduce the risks of complications, creating lucrative opportunities for manufacturers and suppliers in the intravenous equipment market.

Threats

The intravenous equipment sales market faces potential threats that could impact its growth trajectory. One primary concern is the stringent regulatory landscape governing medical devices, which necessitates compliance with rigorous safety and efficacy standards. Manufacturers may encounter challenges related to the lengthy and costly process of obtaining regulatory approvals for new products or modifications to existing devices. Furthermore, fluctuations in healthcare regulations across different regions can complicate market access and limit manufacturers' ability to operate consistently on a global scale. Additionally, the competitive landscape of the intravenous equipment market is marked by rapidly evolving technologies, and companies must continuously innovate to maintain their market position and mitigate the risk of obsolescence.

Another critical threat stems from the increasing prevalence of counterfeit medical devices and products in the healthcare sector. The presence of substandard or counterfeit intravenous equipment can have severe implications for patient safety and treatment efficacy, leading to adverse outcomes. This growing issue poses significant risks to both manufacturers and healthcare providers, as it undermines the integrity of the market and erodes consumer trust. Therefore, stakeholders in the intravenous equipment sales market must remain vigilant against these threats, prioritizing quality assurance and compliance to protect their reputations while ensuring patient safety remains paramount.

Competitor Outlook

• BD (Becton, Dickinson and Company)
• Medtronic
• Fresenius Kabi
• Smiths Medical
• Terumo Corporation
• IVSolutions
• Vygon
• Johnson & Johnson
• Halyard Health
• Cook Medical
• Baxter International
• CareFusion (a part of Becton, Dickinson and Company)
• Hospira (a subsidiary of Pfizer Inc.)
• Medline Industries, Inc.
• Zyno Medical
• Ambu A/S

The competitive landscape of the intravenous equipment sales market is characterized by a mix of established players and emerging companies striving for market share through innovation and diversification. Leading companies such as BD, Medtronic, and Fresenius Kabi have established strong brand identities and significant market presence due to their extensive portfolios of intravenous products. These companies continually invest in research and development to create advanced intravenous devices that cater to the evolving needs of healthcare providers and patients. Furthermore, partnerships and collaborations among manufacturers, distributors, and healthcare facilities are increasingly common as they seek to leverage resources and expertise to enhance product offerings and market reach.

Companies like Terumo Corporation and Smiths Medical are also prominent competitors in the intravenous equipment space. They focus on delivering high-quality, innovative products while emphasizing safety and compliance with regulatory standards. The increasing demand for smart intravenous systems has prompted these companies to prioritize the development of devices equipped with advanced technological features, including real-time monitoring and integrated safety protocols. This trend is indicative of the shifting landscape where technology plays a crucial role in shaping the future of intravenous therapy. Moreover, the competitive environment is further influenced by the push towards value-based care, with manufacturers adapting their strategies to meet the growing need for cost-effective solutions that enhance patient outcomes.

Another factor shaping the competitive landscape is the entry of new players, particularly in the home healthcare segment. As the demand for home-based intravenous therapy grows, companies like Zyno Medical are emerging with innovative, portable solutions tailored for patients and caregivers. These companies are leveraging advanced technologies to develop user-friendly products that cater to the specific needs of the homecare market. The entrance of new entities fosters healthy competition and drives innovation across the industry, ultimately benefiting end users. Furthermore, strategic mergers and acquisitions are common as companies seek to expand their product portfolios and enhance market presence, making the intravenous equipment market a dynamic and competitive space.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Vygon
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Ambu A/S
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Medtronic
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 IVSolutions
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Cook Medical
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Zyno Medical
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Fresenius Kabi
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Halyard Health
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Smiths Medical
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Johnson & Johnson
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Terumo Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Baxter International
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Medline Industries, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 BD (Becton, Dickinson and Company)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Hospira (a subsidiary of Pfizer Inc.)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis
  • 5.16 CareFusion (a part of Becton, Dickinson and Company)
    • 5.16.1 Business Overview
    • 5.16.2 Products & Services
    • 5.16.3 Financials
    • 5.16.4 Recent Developments
    • 5.16.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Intravenous Equipment Sales Market, By End User
    • 6.1.1 Hospitals
    • 6.1.2 Specialty Clinics
    • 6.1.3 Ambulatory Surgical Centers
    • 6.1.4 Homecare Settings
    • 6.1.5 Others
  • 6.2 Intravenous Equipment Sales Market, By Application
    • 6.2.1 Hospitals
    • 6.2.2 Clinics
    • 6.2.3 Ambulatory Surgical Centers
    • 6.2.4 Homecare Settings
    • 6.2.5 Others
  • 6.3 Intravenous Equipment Sales Market, By Product Type
    • 6.3.1 Infusion Pumps
    • 6.3.2 Intravenous Catheters
    • 6.3.3 Intravenous Cannulas
    • 6.3.4 Intravenous Administration Sets
    • 6.3.5 Intravenous Needles
  • 6.4 Intravenous Equipment Sales Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributor Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Intravenous Equipment Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Intravenous Equipment Sales market is categorized based on

By Product Type

• Infusion Pumps
• Intravenous Catheters
• Intravenous Cannulas
• Intravenous Administration Sets
• Intravenous Needles

By Application

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Homecare Settings
• Others

By End User

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Homecare Settings
• Others

By Distribution Channel

• Direct Sales
• Distributor Sales

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• BD (Becton, Dickinson and Company)
• Medtronic
• Fresenius Kabi
• Smiths Medical
• Terumo Corporation
• IVSolutions
• Vygon
• Johnson & Johnson
• Halyard Health
• Cook Medical
• Baxter International
• CareFusion (a part of Becton, Dickinson and Company)
• Hospira (a subsidiary of Pfizer Inc.)
• Medline Industries, Inc.
• Zyno Medical
• Ambu A/S